These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 34023935)
1. Glycosylation is a key in SARS-CoV-2 infection. Reis CA; Tauber R; Blanchard V J Mol Med (Berl); 2021 Aug; 99(8):1023-1031. PubMed ID: 34023935 [TBL] [Abstract][Full Text] [Related]
2. Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein. Ragotte RJ; Pulido D; Donnellan FR; Hill ML; Gorini G; Davies H; Brun J; McHugh K; King LDW; Skinner K; Miura K; Long CA; Zitzmann N; Draper SJ mSphere; 2021 Aug; 6(4):e0064721. PubMed ID: 34378982 [TBL] [Abstract][Full Text] [Related]
3. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells? Gadanec LK; McSweeney KR; Qaradakhi T; Ali B; Zulli A; Apostolopoulos V Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498183 [TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 S glycoprotein binding to multiple host receptors enables cell entry and infection. Trbojević-Akmačić I; Petrović T; Lauc G Glycoconj J; 2021 Oct; 38(5):611-623. PubMed ID: 34542788 [TBL] [Abstract][Full Text] [Related]
6. Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines. Li J; Wang P; Tracey KJ; Wang H Mol Med; 2021 May; 27(1):49. PubMed ID: 34022793 [TBL] [Abstract][Full Text] [Related]
7. Subtle Influence of ACE2 Glycan Processing on SARS-CoV-2 Recognition. Allen JD; Watanabe Y; Chawla H; Newby ML; Crispin M J Mol Biol; 2021 Feb; 433(4):166762. PubMed ID: 33340519 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells. Zheng L; Ma Y; Chen M; Wu G; Yan C; Zhang XE Biochem Biophys Res Commun; 2021 Nov; 579():69-75. PubMed ID: 34592572 [TBL] [Abstract][Full Text] [Related]
9. Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19. Kumar A; Parashar R; Kumar S; Faiq MA; Kumari C; Kulandhasamy M; Narayan RK; Jha RK; Singh HN; Prasoon P; Pandey SN; Kant K J Med Virol; 2022 Apr; 94(4):1300-1314. PubMed ID: 34811761 [TBL] [Abstract][Full Text] [Related]
10. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection. Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM Elife; 2022 Jan; 11():. PubMed ID: 35072628 [TBL] [Abstract][Full Text] [Related]
11. A Deadly Embrace: Hemagglutination Mediated by SARS-CoV-2 Spike Protein at Its 22 N-Glycosylation Sites, Red Blood Cell Surface Sialoglycoproteins, and Antibody. Scheim DE Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269703 [TBL] [Abstract][Full Text] [Related]
12. The Importance of Glycosylation in COVID-19 Infection. Petrović T; Lauc G; Trbojević-Akmačić I Adv Exp Med Biol; 2021; 1325():239-264. PubMed ID: 34495539 [TBL] [Abstract][Full Text] [Related]
13. Variations in SARS-CoV-2 Spike Protein Cell Epitopes and Glycosylation Profiles During Global Transmission Course of COVID-19. Xu W; Wang M; Yu D; Zhang X Front Immunol; 2020; 11():565278. PubMed ID: 33013929 [TBL] [Abstract][Full Text] [Related]
14. Structural Basis of a Human Neutralizing Antibody Specific to the SARS-CoV-2 Spike Protein Receptor-Binding Domain. Yang M; Li J; Huang Z; Li H; Wang Y; Wang X; Kang S; Huang X; Wu C; Liu T; Jia Z; Liang J; Yuan X; He S; Chen X; Zhou Z; Chen Q; Liu S; Li J; Zheng H; Liu X; Li K; Yao X; Lang B; Liu L; Liao HX; Chen S Microbiol Spectr; 2021 Oct; 9(2):e0135221. PubMed ID: 34643438 [TBL] [Abstract][Full Text] [Related]
15. Site-Specific O-glycosylation of SARS-CoV-2 Spike Protein and Its Impact on Immune and Autoimmune Responses. Hanisch FG Cells; 2024 Jan; 13(2):. PubMed ID: 38247799 [TBL] [Abstract][Full Text] [Related]
17. Glycan Masking of Epitopes in the NTD and RBD of the Spike Protein Elicits Broadly Neutralizing Antibodies Against SARS-CoV-2 Variants. Lin WS; Chen IC; Chen HC; Lee YC; Wu SC Front Immunol; 2021; 12():795741. PubMed ID: 34925381 [TBL] [Abstract][Full Text] [Related]
18. Targeting conserved N-glycosylation blocks SARS-CoV-2 variant infection in vitro. Huang HC; Lai YJ; Liao CC; Yang WF; Huang KB; Lee IJ; Chou WC; Wang SH; Wang LH; Hsu JM; Sun CP; Kuo CT; Wang J; Hsiao TC; Yang PJ; Lee TA; Huang W; Li FA; Shen CY; Lin YL; Tao MH; Li CW EBioMedicine; 2021 Dec; 74():103712. PubMed ID: 34839261 [TBL] [Abstract][Full Text] [Related]
19. High-Resolution Linear Epitope Mapping of the Receptor Binding Domain of SARS-CoV-2 Spike Protein in COVID-19 mRNA Vaccine Recipients. Nitahara Y; Nakagama Y; Kaku N; Candray K; Michimuko Y; Tshibangu-Kabamba E; Kaneko A; Yamamoto H; Mizobata Y; Kakeya H; Yasugi M; Kido Y Microbiol Spectr; 2021 Dec; 9(3):e0096521. PubMed ID: 34756082 [TBL] [Abstract][Full Text] [Related]
20. HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry. Wei C; Wan L; Yan Q; Wang X; Zhang J; Yang X; Zhang Y; Fan C; Li D; Deng Y; Sun J; Gong J; Yang X; Wang Y; Wang X; Li J; Yang H; Li H; Zhang Z; Wang R; Du P; Zong Y; Yin F; Zhang W; Wang N; Peng Y; Lin H; Feng J; Qin C; Chen W; Gao Q; Zhang R; Cao Y; Zhong H Nat Metab; 2020 Dec; 2(12):1391-1400. PubMed ID: 33244168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]